Highlights and Quick Summary
- Non-current Liabilities (Other) for the quarter ending September 30, 2022 was $28.2 Million (a -1.41% decrease compared to previous quarter)
- Year-over-year quarterly Non-current Liabilities (Other) increased by 27.9%
- Annual Non-current Liabilities (Other) for 2021 was $22.1 Million (a 131.82% increase from previous year)
- Annual Non-current Liabilities (Other) for 2020 was $9.52 Million (a 169.92% increase from previous year)
- Annual Non-current Liabilities (Other) for 2019 was $3.53 Million (a 612.53% increase from previous year)
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-current Liabilities (Other) of BridgeBio Pharma, Inc.
Most recent Non-current Liabilities (Other)of BBIO including historical data for past 10 years.Interactive Chart of Non-current Liabilities (Other) of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. Non-current Liabilities (Other) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $28.23 | $28.63 | $26.83 | – |
| 2021 | $22.07 | $27.58 | $13.27 | $11.61 | $22.07 |
| 2020 | $9.52 | $13.47 | $9.4 | $2.8 | $9.52 |
| 2019 | – | – | $3.53 | $1.39 | $3.53 |
| 2018 | – | – | – | $0.62 | $0.5 |
| 2017 | – | – | – | – | $0.0 |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology